drugset / Trial / NCT02084004

Effects of Berberine Hydrochloride and Bifidobacterium in Diabetes Mellitus Prevention and Treatment

NCT02084004

Phase 2/3 Withdrawn Xijing Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to assess the beneficial effects of Bifidobacterium Hydrochloride and Berberine on lowering glucose in patients with type 2 diabetes mellitus and to detect the potential mechanism.

Timeline

Start
2015-11
Primary completion
2018-04
Completion
2018-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Berberine Traditional medicine (herbal / TCM) 0.5 g
Subject Bifidobacterium viable pharmaceutics Other / unclassified 2 unknown